Inhibition_NN
of_IN
rat_NN
splenocyte_NN
proliferation_NN
with_IN
methylprednisolone_NN
:_:
in_FW
vivo_FW
effect_NN
of_IN
liposomal_JJ
formulation_NN
._.

The_DT
effect_NN
of_IN
a_DT
liposomal_JJ
formulation_NN
of_IN
methylprednisolone_NN
-LRB-_-LRB-
MPL_NN
-RRB-_-RRB-
on_IN
the_DT
inhibition_NN
of_IN
lymphocyte_NN
proliferation_NN
in_IN
spleen_NN
cells_NNS
was_VBD
investigated_VBN
following_VBG
IV_CD
dosing_NN
in_IN
rats_NNS
._.

Liposomes_NNS
do_VBP
not_RB
alter_VB
the_DT
suppressive_JJ
action_NN
of_IN
MPL_NN
when_WRB
placed_VBN
in_IN
lymphocyte_NN
culture_NN
._.

Rat_NN
splenocytes_NNS
were_VBD
found_VBN
to_TO
have_VB
greater_JJR
sensitivity_NN
to_TO
MPL_NN
-LRB-_-LRB-
EC50_NN
=_JJ
7.9_CD
nM_NN
-RRB-_-RRB-
than_IN
do_VBP
human_JJ
peripheral_JJ
blood_NN
lymphocytes_NNS
-LRB-_-LRB-
EC50_NN
=_JJ
28_CD
nM_NN
-RRB-_-RRB-
._.

In_FW
vivo_FW
studies_NNS
in_IN
rats_NNS
utilized_VBD
2_CD
mg\/kg_NN
IV_CD
bolus_NN
doses_NNS
of_IN
liposomal_JJ
MPL_NN
compared_VBN
to_TO
drug_NN
in_IN
solution_NN
._.

Animals_NNS
were_VBD
sacrificed_VBN
at_IN
various_JJ
times_NNS
post-dosing_JJ
until_IN
120_CD
h_NN
,_,
spleen_NN
was_VBD
excised_VBN
and_CC
,_,
after_IN
incubation_NN
of_IN
lymphocytes_NNS
with_IN
PHA_NN
,_,
splenocyte_NN
blastogenic_JJ
responses_NNS
were_VBD
assessed_VBN
by_IN
measuring_VBG
cellular_JJ
incorporation_NN
of_IN
3H-thymidine_NN
._.

The_DT
suppressive_JJ
effect_NN
of_IN
liposomal_JJ
MPL_NN
in_IN
comparison_NN
with_IN
free_JJ
drug_NN
was_VBD
significantly_RB
prolonged_JJ
-LRB-_-LRB-
&gt;_JJR
120_CD
h_NN
vs_CC
&lt;_JJR
18_CD
h_NN
-RRB-_-RRB-
._.

Inhibition_NN
effects_NNS
versus_CC
time_NN
were_VBD
described_VBN
by_IN
a_DT
pharmacodynamic_JJ
model_NN
using_VBG
MPL_NN
concentrations_NNS
in_IN
plasma_NN
as_IN
an_DT
input_NN
function_NN
._.

A_DT
nonlinear_JJ
relationship_NN
was_VBD
found_VBN
between_IN
suppression_NN
of_IN
splenocyte_NN
proliferation_NN
and_CC
the_DT
concentration_NN
of_IN
bound_VBN
glucocorticoid_NN
receptors_NNS
in_IN
spleen_NN
._.

Only_RB
partial_JJ
receptor_NN
occupancy_NN
accompanied_VBD
complete_JJ
lymphocyte_NN
suppression_NN
._.

The_DT
suppression_NN
of_IN
endogenous_JJ
corticosterone_NN
in_IN
plasma_NN
for_IN
both_DT
treatments_NNS
was_VBD
similar_JJ
with_IN
values_NNS
from_IN
L-MPL_NN
rats_NNS
returning_VBG
to_TO
baseline_NN
after_IN
24_CD
h_NN
._.

These_DT
results_NNS
demonstrate_VBP
enhanced_VBN
efficacy_NN
of_IN
local_JJ
immunosuppression_NN
by_IN
targeting_VBG
spleen_NN
with_IN
liposomal_JJ
MPL_NN
._.

